Tatva Chintan Pharma Chem Limited

Informe acción NSEI:TATVA

Capitalización de mercado: ₹18.9b

Salud financiera de hoja de balance de Tatva Chintan Pharma Chem

Salud financiera controles de criterios 6/6

Tatva Chintan Pharma Chem tiene un patrimonio de accionistas total de ₹7.4B y una deuda total de ₹152.3M, lo que sitúa su ratio deuda-patrimonio en 2.1%. Sus activos y pasivos totales son ₹8.1B y ₹694.2M respectivamente. El BAIT de Tatva Chintan Pharma Chem es de ₹197.1M, por lo que su ratio de cobertura de intereses es de -11.6. Tiene efectivo e inversiones a corto plazo que ascienden a ₹148.7M.

Información clave

2.1%

Ratio deuda-patrimonio

₹152.31m

Deuda

Ratio de cobertura de intereses-11.6x
Efectivo₹148.73m
Patrimonio₹7.38b
Total pasivo₹694.18m
Activos totales₹8.07b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹2.5B) de TATVA superan a sus pasivos a corto plazo (₹678.2M).

Pasivo a largo plazo: Los activos a corto plazo de TATVA (₹2.5B) superan a sus pasivos a largo plazo (₹15.9M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (0.05%) de TATVA se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de TATVA ha pasado de 85% a 2.1% en los últimos 5 años.

Cobertura de la deuda: La deuda de TATVA está bien cubierta por el flujo de caja operativo (259.2%).

Cobertura de intereses: TATVA gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera